Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Castaldo, Ersilia ^a   Sabato, Donata ^a   Lauro, Davide ^a   Sesti, Giorgio ^b   Marini, Maria Adelaide ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTINUOUS INTERSTITIAL GLUCOSE MONITORING; CONTROLLED STUDY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; ULTRASOUND; WAIST CIRCUMFERENCE; AGE; ANTHROPOMETRY; ARTERIAL WALL THICKNESS; BLOOD; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; METABOLISM; METHODOLOGY; MIDDLE AGED; RISK FACTOR; TIME;

ADULT; AGE FACTORS; AGED; ANTHROPOMETRY; ATHEROSCLEROSIS; BLOOD GLUCOSE; CAROTID INTIMA-MEDIA THICKNESS; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIA; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; RISK FACTORS; TIME FACTORS;

EID: 82555168084     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028312     Document Type: Article

References (25)

1. Turnbull FM, Abraira C, Anderson RJ, Byington RP, et al. Control Group (2009) Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 52: 2288-2298.
2. Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, et al. (2009) Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 373: 1765-1772.
3. Yakubovich N, Gerstein HC, (2011) Serious cardiovascular outcomes in diabetes: the role of hypoglycemia. Circulation 123: 342-348.
4. Johnston SS, Conner C, Aagren M, Smith DM, Bouchard J, et al. (2011) Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetes. Diabetes Care 34: 1164-1170.
5. Hilsted J, Bonde-Petersen F, Norgaard MB, Greniman M, Christensen NJ, et al. (1984) Haemodynamic changes in insulin-induced hypoglycaemia in normal man. Diabetologia 26: 328-332.
6. Gogitidze JN, Hedrington MS, Briscoe VJ, Tate DB, Ertl AC, et al. (2010) Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals. Diabetes Care 33: 1529-1535.
7. The DECODE Study Group, the European Diabetes Epidemiology Group (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161: 397-404.
8. Nakagami T, the DECODA Study Group (2004) Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 47: 385-394.
9. Saydah SH, Miret M, Sung J, Varas C, Gause D, et al. (2001) Post-challenge hyperglycaemia and mortality in a national sample of U.S. adults. Diabetes Care 24: 1397-1402.
10. Abdul-Ghani MA, Tripathy D, De Fronzo RA, (2006) Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting Glucose. Diabetes Care 29: 1130-1139.
11. Nathan DM, Davidson MB, Defronzo RA, Heine RJ, Henry RR, et al. (2007) American Diabetes Association. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30: 753-759.
12. Matsuda M, De Fronzo RA, (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470.
13. American Diabetes Association (2011) Standards of medical care in diabetes-2011. Diabetes Care 2011; 34 (Suppl 1): S11-61.
14. Marini MA, Succurro E, Frontoni S, Hribal ML, Andreozzi F, et al. (2007) Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy non-obese women and obese insulin resistant women. Diabetes Care 30: 2145-2147.
15. Cardellini M, Marini MA, Frontoni S, Hribal ML, Andreozzi F, et al. (2007) Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients. Am J Physiol Endocrinol Metab 292: E347-E352.
16. Sachedina N, Pickup JC, (2003) Performance assessment of the Medtronic-MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in Type 1 diabetic subjects. Diabet Med 20: 1012-1015.
17. Derosa G, Salvadeo SA, Mereu R, D'Angelo A, Ciccarelli L, et al. (2009) Continuous glucose monitoring system in free-living healthy subjects: results from a pilot study. Diabetes Technol Ther 11: 159-169.
18. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, et al. (1999) Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 340: 14-22.
19. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853.
20. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, et al. Action to Control Cardiovascular Risk in Diabetes Study Group (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358: 2545-2559.
21. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. ADVANCE Collaborative Group (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358: 2560-2572.
22. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, et al. (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360: 129-139 VADT Investigators.
23. Bonds DE, Miller ME, Bergenstal RM, Buse J, Byington RP, et al. (2010) The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 340: b4909.
24. Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, et al. (2010) Severe hypoglycemia and risks of vascular events and death. N Engl J Med 363: 1410-1418.
25. Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, et al. (2010) Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 375: 481-489.